Products for Research Use Only
RegisterLogin

PND-1186

CAT: 0013-GTR19163966-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19163966-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PND-1186 (VS-4718) is a reversible and selective FAK inhibitor with IC50 of 1.5 nM. Phase 1. (In Vitro) :PND-1186 has an IC50 of ~100 nM in breast carcinoma cells as determined by anti-phospho-specific immunoblotting to FAK Tyr-397.In murine 4T1 breast carcinoma cells, FAK is important in promoting an invasive and metastatic cell phenotype. Increasing concentrations of PND-1186 (0.1 to 1.0 μM) added to 4T1 cells inhibits FAK Tyr-397 phosphorylation (pY397) and results in elevated levels of total FAK protein within 1 h. (In Vivo) :PND-1186 (30 mg/kg or 100 mg/kg; subcutaneously; injected subcutaneously in the neck region) inhibits 4T1 subcutaneous tumor growth by induction of apoptosis.
CAS Number
1061353-68-1
Product Name Alternative
SR 2516 | VS-4718
Purity
>98% (HPLC)
Solubility
DMSO: 24 mg/mL (47.85 mM)
Smiles
O=C (NC) C1=CC=CC=C1NC2=CC (NC3=C (OC) C=C (N4CCOCC4) C=C3) =NC=C2C (F) (F) F
Molecular Formula
C25H26F3N5O3
Molecular Weight
501.5
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2- ((2- ((2-methoxy-4-morpholinophenyl) amino) -5- (trifluoromethyl) pyridin-4-yl) amino) -N-methylbenzamide.

Related Products

CatalogName
GTR19212159-01MSC-1186
GTR19258421-01TO-1187
GTR17987130PndA Antibody
GTR17987508PndA Antibody
GTR19210996-01NMI 1182
GTR19160430-01CPI-1189
GTR19212238TDI-11861
GTR19220197-01Rivulariapeptolides 1185
GTR19213352TDI-11861
GTR19210219-01HMN-1180

Alternative Products

CatalogName
T1950-01PND-1186
FP103465-01PND 1186
T63794-01PND-1186 hydrochloride
MBS130142-01PND-1186 HCl
A13140-5PND-1186 5mg
A13140-2PND-1186 2mg
A13140-100PND-1186 100mg

Popular Products